Clinical Trials Logo

Rhinosinusitis clinical trials

View clinical trials related to Rhinosinusitis.

Filter by:

NCT ID: NCT02582099 Recruiting - Rhinosinusitis Clinical Trials

The Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis and Recurrent Sinusitis

Start date: January 1, 2017
Phase: Phase 4
Study type: Interventional

Topical antibiotic therapy in patients with refractory sinusitis has been shown to improve symptoms, quality of life, and mucosal aspect. In pediatrics allergy clinic at Siriraj hospital since 2006 use Gentamicin nasal irrigation for chronic rhinosinusitis.There have been no prospective studies in gentamicin irrigation in chronic rhinosinusitis.

NCT ID: NCT02403479 Completed - Rhinosinusitis Clinical Trials

The Effectiveness of Topical Silver Colloid in Treating Patients With Recalcitrant Chronic Rhinosinusitis

CRS
Start date: December 10, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Chronic rhinosinusitis without polyposis (CRSsP) is a very common condition that occurs when the lining of the sinuses becomes persistently irritated. Standard management options include topical steroids, antibiotics and surgery, but treatment-resistant CRSsP is frequently encountered. Bacterial biofilms are routinely detected within the nasal mucosa of CRSsP patients and are now thought to play an important role in the protracted nature of the disease. Colloidal silver is a widely used naturopathic agent that has recently been shown to eliminate bacteria, and in particular in vitro sinusitis biofilms, in laboratory studies. Although silver is currently used in a variety of chronic wound therapies, it has not yet been formally studied in people with CRSsP. It is our intention with this project to determine whether colloidal silver is a useful treatment strategy for patients with refractory CRS.

NCT ID: NCT02325596 Enrolling by invitation - Rhinosinusitis Clinical Trials

Investigate the Role of microRNA in Chronic Rhinosinusitis From DC-Th Axis

ITROMICRFDTA
Start date: July 2014
Phase: N/A
Study type: Observational

This study aimed to evaluate the upstream events of Th17/Treg imbalance in CRS and their immune regulatory factors. Then the investigators aimed to explore the regulatory role of miRNA on DC-Th axis and its dysfunction in the pathogenesis of CRS, in order to determine the miRNA expression profile in CRS and clarify the role of miRNA in the pathogenesis of CRS by regulating the DC-Th axis.

NCT ID: NCT02097576 Withdrawn - Rhinosinusitis Clinical Trials

Manuka Honey Nasal Rinse Study

Start date: May 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether high-volume nasal rinses with a manuka honey/saline mixture will improve symptom scores, nasal endoscopic findings and CT scan findings compared to nasal saline rinse without manuka honey in patients with chronic rhinosinusitis. Manuka honey is a honey made from bees that drink the nectar from tea (manuka) trees in New Zealand. It has been shown to have antibacterial activity against common bacteria that cause chronic sinusitis.

NCT ID: NCT02038166 Recruiting - Rhinosinusitis Clinical Trials

Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis

Start date: January 2015
Phase:
Study type: Observational

The purpose of this study is to determine if acquired (partial) Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) deficiency contributes substantially to the pathogenic mechanisms underlying Chronic Rhinosinusitis (CRS), creating a localized environment that impairs mucociliary clearance (MCC).

NCT ID: NCT01955980 Completed - Rhinosinusitis Clinical Trials

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis

Start date: October 27, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The study should create data for the selection of a clinically relevant endpoint to assess the potential of Buparid/PARI SINUS to postpone sinus surgery in patients with chronic Rhinosinusitis.

NCT ID: NCT01946711 Completed - Rhinosinusitis Clinical Trials

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi

Start date: August 28, 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The study should create data for the selection of a clinically relevant primary endpoint to assess the efficacy and safety of Buparid/PARI SINUS as compared to Budes Nasal Spray in the therapy of chronic rhinosinusitis (CRS) with polyposis nasi in adult patients. Ideally, the selected parameter should allow a correlation between an objective methodology and the clinical outcome of the study patients.

NCT ID: NCT01800747 Completed - Acute Otitis Media Clinical Trials

Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)

DAP
Start date: June 2012
Phase: Phase 4
Study type: Interventional

The general hypothesis is that delayed antibiotic treatment strategy present similar effectiveness, when compared with non-prescription of antibiotics or the prescription of antibiotics, in the non-complicated acute respiratory tract infections in pediatric patients.

NCT ID: NCT01771198 Terminated - Rhinosinusitis Clinical Trials

Efficacy Study of SIMVASTATIN to Treat Chronic Rhinosinusitis After Failure of Optimal Treatment

Start date: August 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the clinical efficacy of oral treatment with a statin, SIMVASTATIN 40mg, in a target population of patients with severe chronic rhinosinusitis resistant to surgery followed by conventional medical and surgical treatment.

NCT ID: NCT01680705 Completed - Rhinosinusitis Clinical Trials

Ideal Frequency of Postoperative High Volume Saline Irrigations Following Endoscopic Sinus Surgery

Start date: July 2012
Phase: N/A
Study type: Interventional

The aim of this study is to determine what the ideal frequency of high-volume sinonasal saline irrigation in the early postoperative period following ESS for medically refractory CRS. We will evaluate once, twice, and three times daily frequency sinonasal saline irrigation protocols. Our hypothesis is that three times a day sinonasal saline irrigations for the first week is ideal with no difference between frequencies after 1 week.